Clinical Trial Update: To Determine the Safety of Regorafenib, Hydroxychloroquine, and Entinostat Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update assessing safety of regorafenib, hydroxychloroquine, and entinostat in metastatic colorectal cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Entinostat (entinostat)
• Hydroxychloroquine (hydroxychloroquine)
• Regorafenib (regorafenib)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED | Results posted: 2023-11-09